MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Prevalence and clinical characteristics of young onset Parkinson’s Disease among Nepalese Population

    R. Ojha, B. Gajurel, R. Karn, R. Rajbhandari (Kathmandu, Nepal)

    Objective: To know the prevalence and clinical characteristics of young onset Parkinson’s Disease among Nepalese Population Background: Parkinson’s disease (PD) is a neurodegenerative disease which…
  • 2023 International Congress

    “Grab-the-lock test “ – A novel clinical test for identification of dorsolateral Subthalamic nucleus [STN] during deep brain stimulation [DBS]

    A. Panwar, N. Sawal, M. Matta (SAS Nagar, India)

    Objective: The  target during STN DBS  for Parkinson’s disease is the dorsolateral STN which plays a major role in motor functions in contrast to the venteromedial…
  • 2023 International Congress

    Cued movement preparation and movement coding in human thalamic neurons

    M. Baaske, A. Gulberti, A. Engel, M. Heise, W. Hamel, C. Gerloff, M. Pötter-Nerger, A. Sharott, C. Moll (Lübeck, Germany)

    Objective: To study motor cognition in the human motor thalamus at the single cell and population level. Background: The motor thalamus, in particular its cerebellar-receiving…
  • 2023 International Congress

    Safety and pharmacokinetics of anti-inflammatory NE3107 treatment in carbidopa/levodopa-treated patients with Parkinson’s disease: A phase 2a, double-blind, placebo-controlled study

    J. Aldred, R. Rodriguez, E. Rivera-Rivera, S. Isaacson, R. Kumar, A. Ellenbogen, C. Ahlem, C. Reading, J. Palumbo, N. Osman, A. Lang (Spokane, USA)

    Objective: To assess the safety, tolerability, and pharmacokinetics (PK) of NE3107 in carbidopa/levodopa (C/L)-treated patients with Parkinson’s disease (PD) Background: Disease-modifying therapies that augment the…
  • 2023 International Congress

    The effect of levodopa on the blood activity of calpains in patients with Parkinson’s disease

    Z. Muruzheva, M. Absalyamova, M. Karpenko (Saint-Petersburg, Russian Federation)

    Objective: To evaluate the effect of levodopa on the blood activity of calpains in patients with PD Background: Parkinson's disease (PD) is a chronic progressive…
  • 2023 International Congress

    Chorea improvements over time with once-daily valbenazine treatment in adults with Huntington disease

    E. Furr Stimming, E. Kayson, J. Goldstein, H. Zhang, O. Klepitskaya, G. Liang, D. Haubenberger (Houston, USA)

    Objective: To describe the effects of valbenazine (VBZ) over time on chorea in adults with Huntington disease (HD). Background: The Ph3 KINECTTM-HD (NCT04102579) trial met…
  • 2023 International Congress

    Dyspnea and quality of life in Parkinson’s: a mixed methods study

    M. Darabseh, A. Aburub (Amman, Jordan)

    Objective: This study aimed to explore dyspnea experiences in people living with Parkinson’s PlwP who are walking independently. Background: Dyspnea is one of the non-motor…
  • 2023 International Congress

    Acute laryngeal stridor in the emergency department: pandemic or additional sign?

    F. Gomes, C. Silva, D. Damas, I. Carvalho, I. Cunha, A. Brás, A. Morgadinho, F. Moreira (Coimbra, Portugal)

    Objective: To highlight the importance of early recognition of the broader spectrum of clinical features of MSA and specially the sleep-related breathing disorders, as stridor.…
  • 2023 International Congress

    Spectrum of hyperkinetic movement disorders in a Tunisian Cohort: an observational study

    S. Laroussi, S. Daoud, N. Bouattour, S. Sakka, K. Moalla, M. Damak, N. Farhat, C. Mhiri (Sfax, Tunisia)

    Objective: Recall clinical situations of hyperkinetic movement disorders (HMD) in a Tunisian cohort. Background: HMD result from a dysfunction of the basal ganglia(BG) and are…
  • 2023 International Congress

    Deep Brain Stimulation Duration and Changes in Basal Ganglia Excitatory/Inhibitory Balance in Children and Young Adults with Dystonia

    T. Larsh, D. Gilbert, S. Vadivelu, S. Wu (Cincinnati, USA)

    Objective: We sought to explore associations between basal ganglia aperiodic signals and time since deep brain stimulation (DBS) implantation in children and young adults with…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley